Olema Pharmaceuticals Ownership | Who Owns Olema Pharmaceuticals?

Olema Pharmaceuticals Ownership Summary

Olema Pharmaceuticals is owned by 20.52% institutional investors, 2.16% insiders, and 77.32% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 8.00% of OLMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.79% of its assets in Olema Pharmaceuticals shares.

OLMA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Olema Pharmaceuticals	20.52%	2.16%	77.32%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bain capital life sciences investors	6.84M	8.00%	$67.00M
Paradigm biocapital advisors lp	6.79M	7.95%	$66.51M
Blackrock	4.00M	7.11%	$43.27M
Blackrock funding, inc. /de	5.56M	6.49%	$139.08M
Bvf inc/il	5.30M	6.19%	$51.85M
Vanguard group	3.56M	4.15%	$89.03M
Logos global management lp	3.21M	3.75%	$31.41M
Franklin resources	2.48M	2.89%	$61.92M
Woodline partners lp	2.22M	2.59%	$21.71M
Lightspeed management	1.93M	2.26%	$18.90M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lightspeed management	1.93M	5.87%	$18.90M
Bain capital life sciences investors	6.84M	4.45%	$67.00M
Logos global management lp	3.21M	2.82%	$31.41M
Bvf inc/il	5.30M	2.10%	$51.85M
Paradigm biocapital advisors lp	6.79M	1.89%	$66.51M
Ghost tree capital	550.00K	1.86%	$5.95M
Birchview capital, lp	174.00K	1.29%	$1.70M
Vivo capital	1.51M	1.19%	$14.74M
Highvista strategies	437.18K	1.05%	$4.28M
Kingdon capital management	854.00K	1.04%	$8.36M

Top Buyers

Holder	Shares	% Assets	Change
Jennison associates	964.00K	0.01%	964.00K
Kingdon capital management	854.00K	1.04%	854.00K
Blackrock funding, inc. /de	5.56M	0.00%	836.87K
Blackrock	4.00M	0.00%	782.96K
Boxer capital	650.00K	0.37%	650.00K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-3.47M
Bioimpact capital	-	-	-2.38M
Avoro capital advisors	-	-	-1.65M
Woodline partners lp	2.22M	0.10%	-1.29M
Pictet asset management sa	502.57K	0.01%	-1.13M

New Positions

Holder	Shares	% Assets	Change	Value
Jennison associates	964.00K	0.01%	964.00K	$24.10M
Kingdon capital management	854.00K	1.04%	854.00K	$8.36M
Boxer capital	650.00K	0.37%	650.00K	$7.03M
Skandinaviska enskilda banken ab (publ)	281.69K	0.03%	281.69K	$7.04M
Td asset management	136.40K	0.00%	136.40K	$3.41M

Sold Out

Holder	Change
Swan capital	-1.00
Advisor group	-5.00
Nelson, van denburg & campbell wealth management group	-6.00
Abich financial wealth management	-10.00
Lindbrook capital	-41.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	74	-43.51%	17,589,137	-74.25%	20	0.32%	53	-19.70%	12	-66.67%
Sep 30, 2025	47	-58.77%	11,890,120	-82.11%	13	0.23%	20	-71.43%	15	-37.50%
Jun 30, 2025	119	-10.53%	70,425,751	6.89%	82	1.38%	73	5.80%	25	-43.18%
Mar 31, 2025	10	-93.71%	26,757,361	-62.46%	45	0.29%	5	-94.57%	4	-89.19%
Dec 31, 2024	158	17.04%	71,277,656	21.51%	124	1.19%	91	35.82%	38	-7.32%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.24M	2.79%	6.29K
Vanguard US Total Market Shares ETF	1.49M	2.18%	-
iShares Russell 2000 ETF	1.44M	1.79%	1.44M
Polar Capital Healthcare Opports Inc	1.38M	1.72%	1.38M
Franklin Biotechnology Discv A(acc)USD	1.22M	1.52%	-100.64K
Candriam Global Equities Oncology	860.55K	1.50%	187.55K
Pictet-Biotech P USD	931.49K	1.36%	11.40K
Franklin Small Cap Growth SMA	917.80K	1.34%	917.80K
Franklin Small Cap Growth Adv	893.20K	1.30%	-
Belfius Equities Cure C Cap	1.04M	1.29%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 03, 2026	Mitchell Shawnte	CHIEF LEGAL OFFICER	Sell	$345.15K
Mar 04, 2026	Mitchell Shawnte	CHIEF LEGAL OFFICER	Sell	$600.60K
Mar 04, 2026	Mitchell Shawnte	CHIEF LEGAL OFFICER	Sell	$5.75K
Jan 20, 2026	Harmon Cyrus	-	Sell	$268.80K
Jan 14, 2026	Harmon Cyrus	-	Sell	$101.60K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	12
2025 Q4	-	11
2025 Q3	-	4
2025 Q2	-	-
2025 Q1	1	-

OLMA Ownership FAQ

Who Owns Olema Pharmaceuticals?

Olema Pharmaceuticals shareholders are primarily institutional investors at 20.52%, followed by 2.16% insiders and 77.32% retail investors. The average institutional ownership in Olema Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which Olema Pharmaceuticals falls below.

Who owns the most shares of Olema Pharmaceuticals?

Olema Pharmaceuticals’s largest shareholders are Bain capital life sciences investors (6.84M shares, 8.00%), Paradigm biocapital advisors lp (6.79M shares, 7.95%), and Blackrock (4M shares, 7.11%). Together, they hold 23.06% of Olema Pharmaceuticals’s total shares outstanding.

Does Blackrock own Olema Pharmaceuticals?

Yes, BlackRock owns 7.11% of Olema Pharmaceuticals, totaling 4M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 43.27M$. In the last quarter, BlackRock increased its holdings by 782.96K shares, a 24.34% change.

Who is Olema Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lightspeed management is Olema Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.87% of its assets in 1.93M Olema Pharmaceuticals shares, valued at 18.9M$.

Who is the top mutual fund holder of Olema Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Olema Pharmaceuticals shares, with 2.79% of its total shares outstanding invested in 2.24M Olema Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools